LAM RESEARCH CORP·4

Apr 28, 2:04 PM ET

Harter Ava 4

4 · LAM RESEARCH CORP · Filed Apr 28, 2026

Research Summary

AI-generated summary of this filing

Updated

Lam Research (LRCX) CLO Ava Harter Exercises Options, Sells Shares

What Happened

  • Ava Harter, Chief Legal Officer of Lam Research (LRCX), exercised 6,010 option-derived shares and sold 6,010 shares on 2026-04-27. The exercise shows a reported cost basis of $77.04 per share (total $463,004) and an open-market sale at $258.66 per share (gross proceeds $1,554,547). The filing also lists a derivative disposition of 6,010 shares at $0 (part of the exercise/conversion reporting).

Key Details

  • Transaction date: 2026-04-27; Form 4 filed 2026-04-28 (timely; Form 4s are typically due within two business days).
  • Exercise: 6,010 shares @ $77.04 (total $463,004).
  • Sale: 6,010 shares @ $258.66 (gross proceeds $1,554,547).
  • Additional derivative line: 6,010 shares @ $0 reported as "Disposed" (related to the exercise/conversion).
  • Footnotes: F1 — reported amount includes shares subject to unvested restricted stock units; F2 — the related stock options vest in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.
  • Shares owned after the transaction: Not specified in the provided filing.

Context

  • This was an exercise of options followed by an immediate open‑market sale (a cashless or simultaneous sell-after-exercise pattern). That converts option value into cash for the insider; it is common and does not by itself indicate a view on the company’s prospects.
  • The filing shows both the exercise cost and the sale proceeds; the transactions generated roughly $1.55M in proceeds against $463k exercise cost (before taxes and fees).

Insider Transaction Report

Form 4
Period: 2026-04-27
Harter Ava
Chief Legal Officer
Transactions
  • Exercise/Conversion

    Common Stock

    [F1]
    2026-04-27$77.04/sh+6,010$463,00459,215.455 total
  • Sale

    Common Stock

    [F1]
    2026-04-27$258.66/sh6,010$1,554,54753,205.455 total
  • Exercise/Conversion

    Employee Stock Option (Right to Buy)

    [F2]
    2026-04-276,0106,010 total
    Exercise: $77.04Exp: 2031-08-05Common Stock (6,010 underlying)
Footnotes (2)
  • [F1]The amount reported includes shares subject to unvested restricted stock units.
  • [F2]The stock options will become exercisable in three equal installments on 03/01/2025, 03/01/2026, and 03/01/2027.
Signature
Marta Woods by Power of Attorney|2026-04-27

Documents

1 file
  • 4
    wk-form4_1777399454.xmlPrimary

    FORM 4